
3D Investment Partners Recommends Toho Holdings Shareholders Vote Against the Reappointment of CEO Hiromi Edahiro, and Outside Director Yoshiaki Kamoya and Hidehito Kotani at the Company's 77th Annual General Meeting
TOKYO--(BUSINESS WIRE)--3D Investment Partners Pte. Ltd., the investment manager of 3D Opportunity Master Fund (collectively referred to as '3D' or 'we,' meaning either or both of 3D Investment Partners Pte. Ltd. and 3D OPPORTUNITY MASTER FUND), today released a shareholder presentation highlighting the ongoing and serious corporate governance failures at Toho Holdings Co., Ltd. ('Toho HD' or the 'Company') (TOKYO: 8129). The presentation outlines in detail the reasons why 3D recommends shareholders vote against the reappointment of Representative Director, President and CFO Hiromi Edahiro ('Mr. Edahiro') and, Outside Director Yoshiaki Kamoya ('Mr. Kamoya') and Hidehito Kotani ('Mr. Kotani').
Link to presentation: https://www.3dipartners.com/engagement/toho-maximizing-corporate-value-en-202505.pdf
3D has been a shareholder of Toho HD since 2020 and currently holds approximately 22% 1 of the voting rights, making it one of the Company's largest shareholders. Over the past two years, 3D has engaged in constructive dialogue with Toho HD with the sole aim of enhancing long-term corporate value.
1 Calculated as: (Number of shares held by us + Number of potential shares from convertible bonds with stock acquisition rights held by us) ÷ (Total number of issued shares – Treasury shares + Number of potential shares from convertible bonds with stock acquisition rights held by us).
Management Issues at Toho HD
3D believes that the fundamental management challenges facing Toho HD—specifically, the low profitability of its core business and an inefficient balance sheet—stem from a serious deficiency in its corporate governance structure. In August 2023, we submitted concrete proposals to address these management issues to Toho HD, which were disclosed in our press release dated March 25, 2025. However, due to Toho HD's dysfunctional governance, the Board of Directors was unable to objectively evaluate and implement recommendations which would improve the Company's profitability and value. As a result, the majority of our proposals were dismissed, and the underlying issues remain unresolved.
As long as this governance failure persists, we believe that these management challenges will remain unresolved and long-term corporate value growth will continue to be impaired.
Repeated Scandals and Involvement in the Nihon University Incident
Toho HD has been subject to administrative sanctions for its involvement in bid-rigging on three separate occasions. Nevertheless, the Company has never conducted a thorough investigation of these scandals led by independent experts and has consistently avoided addressing the root causes of its misconduct.
In addition to the bid-rigging incidents, it has recently come to light that Toho HD was involved in a fraudulent scheme related to Nihon University Hospital (the 'Nihon University Incident'). In this case, a part of funds that should have been returned from Toho HD as purchase rebates were instead funneled to third parties by the Company through fictitious consulting contracts, and resulting in the illicit payments. The Company was obviously able to notice that the scheme involved such clear compliance violations at the time of execution since another peer company reportedly refused to participate.
An attitude that is suspected as Concealment
Despite the seriousness of the Nihon University Incident, Toho HD has failed to provide any public explanation. Statements made by Mr. Edahiro during media interviews are in conflict with case records, raising serious concerns about the credibility and transparency of his explanations. Moreover, Toho HD has refused our request to establish a third-party investigative committee that is independent from the Company. Furthermore, during meetings we have had with the Company, senior executives (Shikkoyakuin) have asked us to refrain from further inquiries. This response, among others, can only be interpreted as attempts to conceal the truth.
Toho HD's assertion that "There was no legal violation," and the decision to take no further action, do not meet the standards of governance required for a listed company. What shareholders are demanding is not the mere absence of illegality, but the presence of sufficient transparency and a sound governance framework necessary for long-term corporate value creation.
Risks of Irreparable Damage to Corporate Value
The Board's continued failure to address the Company's compliance issues threatens to erode trust among business partners, potentially leading to revenue losses. This poses the risks of irreparable damage to corporate value. Based on its unwillingness to address these serious issues, we believe the Board of Directors is fundamentally unfit to enhance corporate value.
Our Recommendation Regarding Voting at the General Meeting
In light of the urgent need to rectify Toho HD's governance failures, we strongly recommend that shareholders vote against the reappointment of Mr. Edahiro (Representative Director, President, and CFO), Mr. Kamoya and Mr. Kotani (Outside Directors) for the following reasons:
Regarding Mr. Edahiro:
He was centrally involved in the management of the companies, which are Toho HD or its subsidiary involved in two prior bid-rigging scandals as well as the Nihon University Incident, and must be held accountable for the ongoing governance failures.
His public statements have critically contradicted case records, raising serious concerns about the credibility and transparency of his explanations.
He was appointed CEO without any external comparison or being held accountable for past scandals, through an internal succession process that lacks transparency.
Regarding Mr. Kamoya:
Despite being the longest-serving outside director, he is not a member of the Special Committee on Governance Enhancement, reflecting a troubling indifference toward governance and compliance issues.
Although he should have taken a central role in the Nomination Committee as a previous chairperson thereof, he did not even try to pursue the responsibilities for the past scandals and failed to fulfill his responsibilities of exercising proper oversight in selecting a qualified successor CEO. Furthermore, the internal CEO succession process lacked transparency and, to our knowledge, no attempt was made to look for and evaluate outside candidates.
He currently serves as an advisor to a company with which Toho HD holds cross-shareholdings, casting significant doubt on his independence.
Regarding Mr. Kotani:
As a member of the Nomination Committee, he was involved in last year's process of appointing Mr. Edahiro as CEO.
Furthermore, this year, regarding the decision to reappoint Mr. Edahiro as CEO, Mr. Kotani has not fulfilled his responsibilities as a chairperson of the Nomination Committee who should play the key role of the committee. The internal CEO succession process lacked transparency and, to our knowledge, no attempt was made to look for and evaluate outside candidates.
To Shareholders
As outlined above, we understand that Toho HD is suffering from a critical failure of governance, which in our view has led to the neglect of pressing management issues, the loss of growth opportunities, and significant risk of value destruction due to unresolved compliance concerns.
We respectfully urge shareholders to review our presentation and support the restoration of sound governance and sustainable long-term value creation at Toho HD by voting against the reappointment of Mr. Edahiro, Mr. Kamoya and Mr. Kotani at the Company's upcoming Annual General Meeting.
About 3D Investment Partners Pte. Ltd.
3D Investment Partners Pte. Ltd. is an independent Singapore-based Japan focused value investing fund manager founded in 2015. 3D Investment Partners Pte. Ltd. focuses on partnering with management[s] who share its investment philosophy of medium- to long-term value creation through compound capital growth and a common objective of achieving long-term returns.
Disclaimer
This press release, including annexes is provided for informational purposes only and does not constitute an offer to purchase or sell any security or investment product, nor does it constitute professional or investment advice. This press release should not be relied on by any person for any purpose and is not, and should not be construed as investment, financial, legal, tax or other advice.
3D Investment Partners Pte. Ltd. and its affiliates and related persons ('3DIP') of either believe that the current market price of Toho HD does not reflect its intrinsic value. 3DIP acquired beneficial and/or economic interests based on its own idea that Toho HD securities have been undervalued and provide an attractive investment opportunity and may in the future beneficially own, and/or have an economic interest in, Toho HD securities. 3DIP intends to review its investments in Toho HD on a continuing basis and, depending upon various factors including, without limitation, Toho HD's financial position and strategic direction, the outcome of any discussions with Toho HD, overall market conditions, other investment opportunities available to 3DIP, and the availability of Toho HD securities at prices that would make the purchase or sale of Toho HD securities desirable, 3DIP may, from time to time (in the open market or in private transactions), buy, sell, cover, hedge, or otherwise change the form or substance of any of its investments (including the investment in Toho HD securities) to any degree in any manner permitted by any applicable law, and expressly disclaims any obligation to notify others of any such changes.
3DIP provides no representation or warranty, either expressed or implied, in relation to the accuracy, completeness, or reliability of the information contained herein (including content or quotes from news coverage or other third-party public sources ('Third-Party Materials')), nor is it intended to be a complete statement or summary of the securities, markets, or developments referred to herein. 3DIP expressly disclaims any responsibility or liability for any loss whatsoever arising from any use of, or reliance on, this press release or its contents as a whole or in part by any person, or otherwise whatsoever arising in connection with this press release. 3DIP hereby expressly disclaims any obligation to update or provide additional information regarding the contents of this press release or to correct any inaccuracies in the information contained in this press release.
3DIP disclaims any intention or agreement to be treated as a joint holder (kyodo hoyu sha) under the Financial Instruments and Exchange Act of Japan, a closely related party (missetsu kankei sha) under the Foreign Exchange and Foreign Trade Act with other shareholders, or receiving any power or permission to represent other shareholders in relation to the exercise of their voting rights, and has no intention to solicit, encourage, induce or require any person to cause other shareholders to represent such voting rights.
3DIP does not have the intention to make a proposal, directly or through other shareholders of Toho HD, to transfer or abolish the business or assets of Toho HD and/or Toho HD group companies at the general shareholders meeting of Toho HD. 3DIP does not have the intention or purpose to engage in any conduct which constricts the continuing and stable implementation of business of Toho HD and/or Toho HD group companies.
This press release may include Third-Party Materials. Permission to quote from Third-Party Materials in this press release may neither have been sought nor obtained. The content of the Third-Party Materials has not been independently verified by 3DIP and does not necessarily represent the views of 3DIP. The authors and/or publishers of the Third-Party Materials are independent of, and may have different views to 3DIP. Quoting Third-Party Materials in this press release does not imply that 3DIP endorses or concurs with any part of the content of the Third-Party Materials or that any of the authors or publishers of the Third-Party Materials endorses or concurs with any views which have been expressed by 3DIP on the relevant subject matter. The Third-Party Materials may not be representative of all relevant news coverage or views expressed by other third parties on the stated issues.
In respect of information that has been prepared by 3DIP (and not otherwise attributed to any other party) and which appears in the English language version of this press release, in the event of any inconsistency between the English language version and the Japanese language version of this press release, the meaning of the Japanese language version shall prevail unless otherwise expressly indicated.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
Otto Aviation Standardizes on Galorath's AI-Powered Estimation Platform to Drive Price-to-Win Strategies Across Sustainable Aerospace Initiatives
LONG BEACH, Calif., June 3, 2025 /PRNewswire/ -- Galorath, the premier AI-powered estimation platform provider for cost, schedule, and risk analysis, today announced that Otto Aviation (Otto) is standardizing on its flagship SEER® platform. Otto will leverage the platform's structured operational intelligence to anticipate costs and streamline production efforts as it works to create the future of sustainable air travel through paradigm-shifting design, performance, and economics. In the evolving supply chain landscape, Otto will rely heavily on SEER for Manufacturing (SEER-MFG™) and SEER-3D predictive data modules to develop accurate and efficient manufacturing and assembly costs. SEER allows Otto to build parametric estimates and risk profiles by leveraging historical insights, improving planning precision. The Otto team can interact directly with its proprietary and Galorath-sourced historical data. This simplifies WBS generation and unlocks actionable, data-backed insights earlier in the process. "As we enter the next phase of aircraft development, time-to-market, quality control, and resource accuracy are critical to our success," said Obi K. Ndu, PhD, Chief Information and Digital Officer, Otto Aviation. "Integrating Galorath's SEER platform into workflows ensures we have the right tools to combat economy-driven constraints and focus on cost, outcome predictions, and meeting design requirements, keeping us ahead of the curve with a strategic advantage." Guided by a team of experienced and accomplished aerospace leaders, Otto is ushering in a new era of transonic super-laminar (TSL) aircraft that is more operationally efficient and environmentally friendly. As Otto approaches design initiatives for customers, the SEER-MFG data module empowers Otto with accurate estimation, predictive analytics, risk analysis tools, labor and resource forecasting, and material and production modeling. As designs evolve, the SEER 3D data module allows Otto to update and refresh estimates by generating detailed costs from any CAD system and evaluating cost-saving alternatives. "Delivering sustainable flight innovation demands precision, flexibility, and rigorous control. Galorath's AI-powered estimation platform brings structure to that complexity," said Charles Orlando, Chief Strategy Officer at Galorath. "The complexities of navigating quality control issues, new regulations, and persistent supply chain constraints require a sophisticated solution. Galorath's AI-powered estimation platform delivers structured cost, schedule, and risk analysis through a unified environment that scales across Otto team members and designs." SEER AI-Powered Estimation and Planning Built on Galorath's trusted SEER modeling framework, the platform combines analytical depth with intuitive access. SEER's core modeling framework is refined over decades of complex program execution that addresses the needs of cost, schedule, labor, risk, should-cost, and price-to-win estimation and analysis for hardware, software, manufacturing, and information technology (IT). The platform's operational intelligence layer, SEERai™, is integrated throughout the experience. It enables natural interaction, embedded guidance, and intelligent automation – reducing cycle time, improving alignment, and unlocking knowledge trapped in documents, processes, and expert memory. For more information about the SEER platform, visit About Otto Aviation Otto is creating ultra-efficient, sustainable flight through paradigm-shifting technologies. Otto distinguishes itself as an aerospace trailblazer through its selection to participate in the OECIF-resourced, DARPA-led Energy Web Aircraft program, showcasing a strong commitment to innovation. For more information, visit About Galorath Incorporated Galorath delivers an AI-powered business operations platform grounded in decades of real-world cost, schedule, and risk validation for operations, supply chains, and manufacturing. Their flagship SEER® platform is trusted by industry giants in high-stakes environments, like Accenture, NASA, Boeing, the U.S. Department of Defense, and BAE Systems (EU), among others. Built on Galorath's trusted SEER modeling framework, the platform combines analytical depth with intuitive access to accelerate time to market, enhance project predictability and visibility, and ensure project costs are on track. For more information, visit SEER is a registered trademark of Galorath Incorporated. SEER-MFG and SEERai are trademarks of Galorath Incorporated. All other trademarks are the property of their respective owners. This press release may contain forward-looking statements that involve risks and uncertainties, including statements regarding the future financial performance, business strategies, market conditions, and product development plans of the companies mentioned. Actual results may differ materially from those expressed or implied in these forward-looking statements due to various factors, including those discussed in filings with the Securities and Exchange Commission. The companies mentioned here undertake no obligation to update any forward-looking statements contained herein, whether due to new information, future events, or otherwise. View original content to download multimedia: SOURCE Galorath Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30-05-2025
- Yahoo
Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain?
Illumina Inc. ILMN recently introduced PromoterAI, a new AI algorithm that accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome. PromoterAI turns data into insights to help researchers accelerate new breakthroughs in diagnosis for rare diseases. It is the latest addition to the company's artificial intelligence ("AI") and software portfolio. Since the announcement on May 29, ILMN's shares declined 0.2%, closing at $84.28 yesterday. The company is breaking new ground with AI technology. In 2019, the Illumina Artificial Intelligence Lab released SpliceAI, a deep learning tool for interpreting noncoding cryptic splice mutations. In 2023, Illumina released PrimateAI-3D, which predicts the pathogenicity of protein-coding variants based on evolutionary conservation and protein structure. PromoterAI is the latest genomic AI algorithmic innovation from Illumina. As a result, we expect the news to boost market sentiment toward ILMN stock. Illumina presently has a market capitalization of $13.34 billion. The company's earnings yield of 5.1% sits comfortably against the industry's -31.7%. It delivered a trailing four-quarter average earnings surprise of 56.4%. Built on state-of-the-art deep learning neural networks, PromoterAI brings unprecedented precision to the interpretation of promoter variants. With PromoterAI applied to whole-genome sequencing ("WGS") data analysis, clinical researchers are empowered to better understand the etiology and drug target potential for rare genetic diseases, common diseases and oncology. PromoterAI will be accessible through Illumina Connected Software, and it is now available as part of DRAGEN secondary analysis. Precomputed PromoterAI scores for all human promoter single-nucleotide variants are freely available for academic and noncommercial research use. Currently, only about 30% of rare disease patients receive an accurate diagnosis from exome sequencing. For many patients, insights may be hidden in what are known as "noncoding regions," which comprise over 98% of the genome and may hold the key to increasing the diagnostic rate. Promoters are key noncoding elements that define where transcription of a gene begins. When promoters are disrupted by genetic mutations, it can have profound consequences for downstream gene expression. The PromoterAI algorithm interprets the genetic sequence of promoters, thus opening the door to precise diagnoses for more patients with rare diseases. Image Source: Zacks Investment Research Per Dimension Market Research's report, AI in the genomics market is estimated to be valued at $1.40 billion in 2025. It is further anticipated to reach $44.93 billion by 2034 at a compound annual growth rate of 47%. Key factors driving the market growth are increasing demand for precision medicine, rising R&D expenditure and growing demand for effective handling tools for managing large data. On Tuesday, Illumina received approval from Japan's Ministry of Health, Labour and Welfare for TruSightTM Oncology (TSO) Comprehensive for Class III/IV Medical Device (Specially Controlled Medical Device). The TSO Comprehensive is the first U.S. FDA-approved, distributable comprehensive genomic profiling in vitro diagnostics (IVD) kit with pan-cancer CDx claims in the United States. Over the past three months, ILMN's shares have risen 0.1% against the industry's 8.5% decline. Illumina currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space include Phibro Animal Health PAHC, Hims & Hers Health HIMS and Prestige Consumer Healthcare PBH. While Phibro Animal Health sports a Zacks Rank #1 (Strong Buy) at present, Hims & Hers Health and Prestige Consumer Health carry a Zacks Rank #2 (Buy) each. You can see the complete list of today's Zacks #1 Rank stocks here. Estimates for Phibro Animal Health's fiscal 2025 earnings per share have jumped 3.6% to $2.01 in the past 30 days. Shares of the company have rallied 37.9% in the past year compared with the industry's 10.1% growth. Its earnings yield of 8.7% compares comfortably with the industry's 0.5%. PAHC's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 30.6%. Hims & Hers Health's shares have surged 172.5% in the past year. Estimates for the company's 2025 earnings per share have jumped 12.5% to 72 cents in the past 30 days. HIMS' earnings beat estimates in two of the trailing four quarters, matched in one and missed in the other, the average surprise being 19.6%. In the last reported quarter, it posted an earnings surprise of 66.7%. Estimates for Prestige Consumer Healthcare's fiscal 2026 earnings per share have increased 1 cent to $4.77 in the past 30 days. Shares of the company have jumped 37.2% in the past year compared with the industry's 10.1% growth. PBH's earnings surpassed estimates in three of the trailing four quarters and matched on one occasion, the average surprise being 2.8%. In the last reported quarter, it delivered an earnings surprise of 1.5%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Illumina, Inc. (ILMN) : Free Stock Analysis Report Prestige Consumer Healthcare Inc. (PBH) : Free Stock Analysis Report Phibro Animal Health Corporation (PAHC) : Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
27-05-2025
- Yahoo
Pearl Becomes First Dental AI Company Cleared by FDA for Both 2D and 3D Imaging
Second Opinion® 3D expands Pearl's industry-leading AI capabilities to CBCT imaging—solidifying its position as the most advanced dental AI platform in the world LOS ANGELES, May 27, 2025--(BUSINESS WIRE)--Pearl, the global leader in dental AI solutions, today announced that it has received FDA 510(k) clearance for Second Opinion® 3D, making Pearl the first and only dental AI company with FDA-cleared solutions for both 2D and 3D dental radiologic image analysis. With this new clearance, Pearl's Second Opinion® platform extends its AI capabilities to cone beam computed tomography (CBCT) imaging, enabling automated identification of critical anatomical structures—including dentition, maxilla, mandible, inferior alveolar canal and mental foramen (IAN), maxillary sinus, nasal space, and airway—in 3D scans. "Pearl's mission has always been to deliver the most advanced and clinically trusted AI solutions in dentistry," said Ophir Tanz, founder and CEO of Pearl. "Becoming the first company to achieve FDA clearance for both 2D and 3D radiologic analysis isn't just a milestone for us—it's a milestone for dentistry." Second Opinion® 3D is designed to assist dental professionals in reviewing CBCT scans with greater speed, accuracy, and clarity. It empowers clinicians with instant AI-powered visualizations that support more precise diagnostics and treatment planning across specialties, including implantology, orthodontics, oral surgery, and airway management. The FDA clearance follows extensive bench performance testing, in which Second Opinion® 3D demonstrated high segmentation accuracy across all targeted anatomical structures. Dice Similarity Coefficient scores exceeded clinical thresholds for every category, confirming both safety and effectiveness. This clearance builds on Pearl's track record as a regulatory leader in dental AI. The company's original Second Opinion® platform remains the most widely deployed FDA-cleared solution for chairside AI pathology detection in 2D radiographs. With the addition of 3D capabilities, Pearl now delivers the only FDA-cleared platform capable of supporting comprehensive radiologic review across both major dental imaging modalities. About Pearl Pearl is an AI-driven company committed to enhancing patient care in dentistry. Founded in 2019 by a team with decades of experience developing successful, enterprise-grade computer vision solutions, Pearl introduced the first-ever FDA-cleared AI capable of reading and instantly identifying diseases in dental x-rays. With regulatory clearance in 120 countries, Pearl's AI assists dentists in making precise clinical decisions and effectively communicating with patients, thereby transforming the dental care experience worldwide. As dentistry's global AI leader, Pearl is committed to the ongoing innovation of robust, accessible AI tools that improve patient health outcomes and build greater trust in dental medicine. To request a demo, please visit View source version on Contacts Media Contact Kate Gundrypearl@ 617-797-5174 Sign in to access your portfolio